Dr. Michael McKenzie, MD - Publications 1. McKenzie MR, Souhami L, Podgorsak EB, Olivier A, Caron J L, Villemure J G: Photon radiosurgery: A clinical review. Can J Neurosciences 1992 (May); 19(2):212 221. 2. McKenzie MR, Freeman CR, Pla M, Guerra J, Souhami L, Podgorsak EB: Clinical experience with electron pseudoarc therapy. Brit J Radiol 1993 (March); 66(783):234-240. 3. McKenzie MR, Wong FLW, Epstein JLB, Lepawsky ML: Hyperbaric oxygen and post radiation osteonecrosis of the mandible. Oral Oncol, Europ J Cancer 1993 (July); 29B(3):201-207. 4. McKenzie MR, Souhami L, Caron J-L, Olivier A, Villemure J-G, Podgorsak EB: Early and late complications following dynamic stereotactic radiosurgery and fractionated stereotactic radiotherapy. Can J Neurol Sci 1993(Nov); 20(4):279-285. 5. Leong C, McKenzie MR, Coupland DB, Gascoyne RD: Disseminated intravascular coagulation in a patient with metastatic prostate cancer: Fatal outcome following strontium-89 therapy. J Nuclear Med 1994 (Oct); 35(10):1662- 1664. 6. Wong E, Lam S, Grafton C, Wong F, Morris W, McKenzie M, Goddard K, Yuen K: HDR brachytherapy for obstructive bronchial tumors. J Bronchol 1994;1(2):99-104. 7. Epstein J, van der Meij E, McKenzie M, Wong F, Lepawsky, Stevenson-Moore P: Postradiation osteonecrosis of the mandible: A long-term follow-up study. Oral Surg Oral Pathol Oral Radiol Endodont 1997 (Jun);83(6):657-662. 8. McLaren D, McKenzie M, Duncan G, Pickles T: Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behaviour in early untreated prostate cancer. Cancer 1998 (Jan);82(2):342-348. 10. Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie, Wong F, Morris J, Grafton C, Tsang, V, Goddard K, Murphy K, Parsons C, Amy R, Page R: New combination of the old drugs for elderly patients with small-cell lung cancer: A Phase II study of the PAVE regimen. J Clin Oncol 1998 (May);16(5):1940-1947. 11. McKenzie MR: Palliative care and oncology: Linking the two solitudes. Can Med Ass J 1998 (Jun);158(13):1702-1704. 12. Pickles T, Goodman GB, Fryer CJ, Bowen J, Coldman A, Duncan GG, Graham P, McKenzie M, Morris WJ, Rheaume DE, Syndikus I. Pion conformal radiation of prostate cancer: Results of a randomized study. Int J Radiat Oncol Biol Phys 1999 (Jan);43(1):47-55. 13. Truant T, McKenzie MR. Discussing complementary therapies: There’s more than efficacy to consider (editorial). Can Med Ass J 1999 (Feb);160(3):351-352. 14. McKenzie M, MacLennan I, Kostashuk E, Bainbridge T: Post-irradiation sarcoma after external beam radiation therapy for localized adenocarcinoma of the prostate: Report of three cases. Urology 1999 (Jun);53(6):1228. 15. Clark BG, McKenzie MR: Radiation techniques for the 21st Century. Can Med Ass J 1999 (Nov);161(10):1292. 16. Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F: Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. J Clin Oncol 2001 (Nov);19(21):4126-4134. 17. Pickles T, Agranovich A, Berthelet E, Duncan GG, Keyes M, Kwan W, McKenzie MR, Morris WJ: Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma. Cancer 2002 (Jan);94(2):362-367. 18. Sidhu S, Morris WJ, Spadinger I, Keyes M, Hilts M, Harrison R, Otto K, McKenzie M, Agranovich A: Prostate brachytherapy postimplant dosimetry: A comparison of prostate quadrants. Int J Radiat Oncol Biol Phys 2002 (Feb);52(2):544-552. 19. Quirt I, Robeson C, Lau, CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F: Epoetin alfa in patients not on chemotherapy – Canadian data. Semin Oncol 2002 Jun;29(3 Suppl 8):75-80. 20. Wright JR, McKenzie M, DeAngelis C, Foroudi F, Paul N, Rajaraman M, Wong F, Wong R, Wong KS: Radiation induced mucositis: Co-ordinating a research agenda. Clin Oncol (Royal Coll Rad) 2003 Dec;15(8)473-477. 21. Liu M, Pickles T, Agranovich A, Berthelet, Duncan G, Keyes M, Kwan W, McKenzie M, Morris J, Pai H, Tyldesley S, Wu J: Impact of neoadjuvant androgen ablation and other factor on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys 2004 Jan;58(1):59-67. 22. Chung HT, Ma R. Toyota, Clark B, Robar J, McKenzie M. Audiologic and treatment outcomes following linear accelerator-based stereotactic irradiation for acoustic neuroma. Int J Rad Oncol Biol Phys 2004 July;59(4):1116-1121. 23. Liu M, Pickles T, Berthelet E, Agranovich A, Kwan W, Tyldesley S, McKenzie M, Keyes M, Morris J, Pai. Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol 2005 Feb;74(2):197- 201. 24. Keyes M, Schellenberg, D, Moravan V, McKenzie M, Agranovich A, Pickles T, Wu J, Liu M, Bucci J, Morris J. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve? 2006 Feb;64(3):825-834. 25. Tyldesley S, Voduc D, McKenzie M, Duncan G, Liu M, Wu D. Surveillance of Stage I Testicular Seminoma: The British Columbia Cancer Agency Experience 1992 to 2002. Urology 2006 March;67(3):594-598. 26. Wong RKS, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman, I, Souhami L, Chabot P, Pater J. 5-Hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation-induced emesis: A placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC.19). J Clin Oncol 2006 Jul;24(21):3458-3464. 27. Candish C, McKenzie M, Clark BG, Ma R, Lee R, Vollans E, Robar J, Gete E, Martin M. Stereotactic fractionated radiotherapy for the treatment of benign meningiomas. Int Radiat Oncol Biol Phys 2006;4 (Supp):S3-S6. 28. Clark B, McKenzie M, Robar J, Vollans E, Candish C, Toyota B, Lee A, Ma R, Goddard K, Erridge S. Does intensity modulation improve healthy tissue sparing in stereotactic radiosurgery of complex arteriovenous malformation? Med Dosim 2007;32(3):172-180. 29. Thomas C, Di Maio S, Ma R, Vollans E, Chu, C, Clark B, Lee R, McKenzie M, Martin M, Toyota B. Hearing preservation following stereotactic fractionated radiotherapy for vestibular schwannomas: Prognostic implications of cochlear dose. J Neurosurg 2007 Nov;107(4):918-926. 30. Olson R, Chhabanai T, McKenzie M. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Supp Care Cancer 2008 Nov;16(11):1273-1278. 31. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K. Volumetric Modulated Arc Therapy (VMAT) for delivery of prostate radiotherapy: comparison with Intensity Modulated Radiotherapy (IMRT) and 3-Dimensional Conformal Radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2008 Nov;72(4):996-1001. 32. Oliffe JL, Halpin M, Bottorff JL, Hislop TG, McKenzie M, Mroz L. How prostate cancer support groups do and do not survive: British Columbian Perspectives. Am J Men’s Health 2008 June;2(2):143-155. 33. Clark B, Candish C, Vollans E, Gete E, Lee R, Martin M, Ma R, McKenzie M. Optimization of stereotactic radiotherapy treatment delivery technique for base-of-skull meningiomas. Med Dosim 2008; 33(3):239-247. 34. Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, Lapointe V, Halperin R, Morris WJ. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Outcomes of 712 men. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1023-32. 35. Morris WJ, Keyes M, Palma D, McKenzie MR, Spadinger I, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Lapointe V, Berthelet E, Pai H, Harrison R, Kwa W, Bucci J, Racz V, and Woods, R. Evaluation of Dosimetric Parameters and Disease Response in 1006 consecutive patients treated with 125 Iodine transperineal brachytherapy for low- and intermediate- risk prostate cancer. Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys 2009 April;73(5):1432-1438. 36. Morris WJ, Keyes M, Palma D, Spadinger I, McKenzie MR, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Berthelet E, Pai H. A population based study of biochemical and survival outcomes following permanent 125 Iodine brachytherapy for low- and intermediate-risk prostate cancer. Urology 2009 Apr;73(4):860-865. 37. Pugh TJ, Keyes M, Barclay L, Delaney A, Krzywinski M, Thomas D, Yang C, Agranovich A, McKenzie M, Morris WJ, Pickles T, Marra MA, Moore RA. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res 2009 August; 15(15):5008-5016. 38. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, Schmuland M, Ma R, McKenzie M, Otto K. A comparison of volumetric modulated arc therapy (VMAT) and conventional intensity modulated radiotherapy (IMRT) for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 2010 March;76(4)1177-1184. 39. Olson R, Parkinson M, McKenzie M. Selection Bias Introduced by Neuropsychological Assessments. Can J Neurosciences 2010 March;37(2):264-268. 40. Roberge D, Menard C, Bauman G, Chan, A, Mulroy L, Sahgal A, Malone S, McKenzie M, Schroeder G, Fortin M-A, Ebacher A, Milosevic M. Radiosurgery scope of practice in Canada: A report of the Canadian Association of Radiation Oncology (CARO) Advisory Committee.